Results 271 to 280 of about 46,608 (304)
Some of the next articles are maybe not open access.
Alpha Glucosidase Inhibitory Activities of Plants with Focus on Common Vegetables
Plants, 2020Samuel Tilahun Assefa +2 more
exaly
Pharmacology of alpha-glucosidase inhibition.
European journal of clinical investigation, 1995The development of alpha-amylase and brush-border alpha-glucosidase inhibitors is reviewed. The mode of action as well as pharmacological and pharmacodynamic properties of selected inhibitors with special regard to the most thoroughly investigated alpha-glucosidase inhibitor acarbose are discussed. Inhibition of intestinal alpha-glucosidases delays the
openaire +1 more source
Potential antiradical and alpha-glucosidase inhibitors from Ecklonia maxima (Osbeck) Papenfuss
Food Chemistry, 2013Rengasamy Ragupathi Raja Kannan +1 more
exaly
Inhibition of Alpha-glucosidase and Amylase by Luteolin, a Flavonoid
Bioscience, Biotechnology and Biochemistry, 2000Jong-Sang Kim, Son Kun Ho
exaly
[Alpha-glucosidase inhibitor].
Nihon rinsho. Japanese journal of clinical medicine, 2012Tsuyoshi, Ohkura, Shin-Ichi, Taniguchi
openaire +1 more source
[Specificity of fungal alpha-glucosidases].
Biokhimiia (Moscow, Russia), 1977Studies of substrate and cosubstrate specificities of mould alpha-glucosidases suggest that the binding site of the active center of mould alpha-glucosidase consits of two subsites--glucone and aglucone ones. The glucone site is capable to bind glucose and mannose, whereas the aglucone one- some compounds whose affinity for the enzyme may be expressed ...
openaire +1 more source
alpha-Glucosidase inhibition in obesity.
Acta medica Scandinavica. Supplementum, 1986Acarbose is an alpha-glucosidase inhibitor which reversibly and competitively inhibits the digestion of oligo- and disaccharides at the brush border of the small intestine. This study evaluates the preventive and therapeutic properties of acarbose in the treatment of obesity. Dose-response experiments were performed during repeated sucrose loads in man
openaire +1 more source
Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation
Diabetes and Vascular Disease Research, 2012Eberhard Standl, Oliver Schnell
exaly

